Literature DB >> 15779036

Improved artery delineation in dual-stack coronary magnetic resonance angiography using parallel imaging at 3 T.

Michael E Huber1, Sebastian Kozerke, Peter Boesiger.   

Abstract

PURPOSE: To improve vessel sharpness and T2 preparation (T2Prep) in dual-stack three-dimensional coronary magnetic resonance angiography (MRA) by shortening the time delays between the magnetization preparation pulses and the imaging stacks using sensitivity encoding (SENSE) at 3 T.
MATERIALS AND METHODS: By combining dual-stack three-dimensional coronary MRA with the parallel imaging technique SENSE at 3 T, the acquisition duration of each three-dimensional imaging stack was shortened by a factor of 2. The proposed technique was implemented and tested in experiments with a moving phantom and in measurements on six healthy volunteers.
RESULTS: The time delay between the navigator, T2Prep, and second imaging stack was reduced by 37%, relative to conventional dual-stack angiography without parallel imaging. This enabled the achievement of comparable high-vessel sharpness values for the left and the right coronary arteries relative to values known from conventional single-stack three-dimensional coronary MRA at 3 T.
CONCLUSION: Parallel imaging allows for improved vessel visualization in dual-stack coronary MRA, given shorter temporal delays between navigator, T2Prep, and the actual image acquisitions, and thus considerably facilitates simultaneous acquisition of high-resolution angiograms of the left and right coronary systems. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15779036     DOI: 10.1002/jmri.20277

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  1 in total

1.  Coronary MR angiography at 3T during diastole and systole.

Authors:  Ahmed M Gharib; Daniel A Herzka; Ali O Ustun; Milind Y Desai; Julia Locklin; Roderic I Pettigrew; Matthias Stuber
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.